department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Jazz Pharmaceuticals plc ($JAZZ) · pipeline · pharmadog

← back to Jazz Pharmaceuticals plc

Pipeline · $JAZZ

14 products

Marketed(calcium oxybate + magnesium oxybate + potassium oxybate + sodium oxybate)Xywav (sodium oxybate)Cataplexy Marketed(cytarabine hydrochloride + daunorubicin hydrochloride)Vyxeos ((cytarabine hydrochloride + daunorubicin hydrochloride))Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)MarketedRylazeRylaze (asparaginase erwinia chrysanthemi-rywn)Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)MarketedSODIUM OXYBATESODIUM OXYBATE (SODIUM OXYBATE)Cataplexy MarketedcannabidiolEpidiolex (cannabidiol)Infantile Spasm (West Syndrome)Marketeddefibrotide sodiumDefitelio (defibrotide sodium)Hepatic Veno-Occlusive Disease Marketeddordaviprone hydrochlorideModeyso (dordaviprone hydrochloride)Glioma MarketedlurbinectedinZepzelca (lurbinectedin)Ewing Sarcoma Phase 2cannabidivarinAutism Spectrum Disorder (ASD)Phase 1JZP-3507Ependymoma Phase 1JZP-898Gastroesophageal (GE) Junction Carcinomas Phase 1flezurafenibHematological Tumor ZEPZELCAZEPZELCA (LURBINECTEDIN)1 INDICATIONS AND USAGE ZEPZELCA is an alkylating drug indicated: • in combination with atezolizumab or atezolizumab and hyaluronidase-tqjs, for the maintenance treatment of adult patients with extensive-stage small cell lung cancer whose disease has not progressed after first-line induction therapy with atezolizumab or atezolizumab and hyaluronidase-tqjs, carboplatin and etoposide. ( 1.1 ) • For the treatment of adult patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy. ( 1.2 ) This indication is approved under accelerated approval based on overall response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s). ( 1.2 ) 1.1 Extensive-Stage Small Cell Lung Cancer ZEPZELCA, in combination with atezolizumab or atezolizumab and hyaluronidase-tqjs, is indicated for the maintenance treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC) whose disease has not progressed after first-line induction therapy with atezolizumab or atezolizumab and hyaluronidase-tqjs, carboplatin and etoposide. 1.2 Metastatic Small Cell Lung Cancer ZEPZELCA is indicated for the treatment of adult patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy. This indication is approved under accelerated approval based on overall response rate and duration of response [see Clinical Studies (14) ] . Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).pre_registrationzanidatamabZiihera (zanidatamab-hrii)Adenocarcinoma Of The Gastroesophageal Junction